Similar articles

Abstract: tacrolimus (TAC), also called FK506, is one of the classical immunosuppressants to prevent allograft rejection after liver transplantation. However, it has been proved to be associated with post-transplant hyperlipemia. The mechanism behind this is unknown, and it is urgent to explore preventive strategies for hyperlipemia after transplantation. Therefore, we established a hyperlipemia mouse model to investigate the mechanism, by injecting TAC intraperitoneally for eight weeks. After TAC treatment, the mice developed hyperlipemia (manifested as elevated triglyceride (TG) and low-density lipoprotein cholesterol (LDL-c), as well as decreased high-density lipoprotein cholesterol (HDL-c)). Accumulation of lipid droplets was observed in the liver. In addition to lipid accumulation, TAC induced inhibition of the autophagy-lysosome pathway (microtubule-associated protein 1 light chain 3β (LC3B) II/I and LC3B II/actin ratios, transcription factor EB (TFEB), protein 62 (P62), and lysosomal-associated membrane protein 1 (LAMP1)) and downregulation of fibroblast growth factor 21 (FGF21) in vivo. Overexpression of FGF21 may reverse TAC-induced TG accumulation. In this mouse model, the recombinant FGF21 protein ameliorated hepatic lipid accumulation and hyperlipemia through repair of the autophagy-lysosome pathway. We conclude that TAC downregulates FGF21 and thus exacerbates lipid accumulation by impairing the autophagy-lysosome pathway. Recombinant FGF21 protein treatment could therefore reverse TAC-caused lipid accumulation and hypertriglyceridemia by enhancing autophagy.

成纤维细胞生长因子21通过TFEB介导的脂噬缓解他克莫司引起的肝脏脂质积聚

[1]AchilaOO, FessahyeN, MengistuST, et al., 2022. A community based cross sectional study on the prevalence of dyslipidemias and 10 years cardiovascular risk scores in adults in Asmara, Eritrea. Sci Rep, 12:5567.

[2]BallabioA, BonifacinoJS, 2020. Lysosomes as dynamic regulators of cell and organismal homeostasis. Nat Rev Mol Cell Biol, 21(2):101-118.

[3]ByunS, SeokS, KimYC, et al., 2020. Fasting-induced FGF21 signaling activates hepatic autophagy and lipid degradation via JMJD3 histone demethylase. Nat Commun, 11:807.

[4]ChenLQ, WangK, LongAJ, et al., 2017. Fasting-induced hormonal regulation of lysosomal function. Cell Res, 27(6):748-763.

[5]ChoiSW, ReddyP, 2014. Current and emerging strategies for the prevention of graft-versus-host disease. Nat Rev Clin Oncol, 11(9):536-547.

[6]DehghaniSM, TaghaviSAR, EshraghianA, et al., 2007. Hyperlipidemia in Iranian liver transplant recipients: prevalence and risk factors. J Gastroenterol, 42(9):769-774.

[7]FisherFM, Maratos-FlierE, 2016. Understanding the physiology of FGF21. Annu Rev Physiol, 78:223-241.

[8]GengLL, LamKSL, XuAM, 2020. The therapeutic potential of FGF21 in metabolic diseases: from bench to clinic. Nat Rev Endocrinol, 16(11):654-667.

[9]HondaresE, IglesiasR, GiraltA, et al., 2011. Thermogenic activation induces FGF21 expression and release in brown adipose tissue. J Biol Chem, 286(15):12983-12990.

[10]InagakiT, DutchakP, ZhaoGX, et al., 2007. Endocrine regulation of the fasting response by PPARα-mediated induction of fibroblast growth factor 21. Cell Metab, 5(6):415-425.

[11]KlionskyDJ, Abdel-AzizAK, AbdelfatahS, et al., 2021. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition). Autophagy, 17(1):1-382.

[12]KurosuH, ChoiM, OgawaY, et al., 2007. Tissue-specific expression of βKlotho and fibroblast growth factor (FGF) receptor isoforms determines metabolic activity of FGF19 and FGF21. J Biol Chem, 282(37):26687-26695.

[13]LiZ, MiaoZY, DingLL, et al., 2021. Energy metabolism disorder mediated ammonia gas-induced autophagy via AMPK/mTOR/ULK1-Beclin1 pathway in chicken livers. Ecotoxicol Environ Saf, 217:112219.

[14]LingQ, HuangHT, HanYQ, et al., 2020. The tacrolimus-induced glucose homeostasis imbalance in terms of the liver: from bench to bedside. Am J Transplant, 20(3):701-713.

[15]LiuKP, QiuDB, LiangX, et al., 2022. Lipotoxicity-induced STING1 activation stimulates MTORC1 and restricts hepatic lipophagy. Autophagy, 18(4):860-876.

[16]LiuLH, TaoZP, ZhengLD, et al., 2016. FoxO1 interacts with transcription factor EB and differentially regulates mitochondrial uncoupling proteins via autophagy in adipocytes. Cell Death Discov, 2:16066.

[17]MarkanKR, NaberMC, AmekaMK, et al., 2014. Circulating FGF21 is liver derived and enhances glucose uptake during refeeding and overfeeding. Diabetes, 63(12):4057-4063.

[18]MedinaDL, 2021. Lysosomal calcium and autophagy. Int Rev Cell Mol Biol, 362:141-170.

[19]NezichCL, WangCX, FogelAI, et al., 2015. MiT/TFE transcription factors are activated during mitophagy downstream of Parkin and Atg5. J Cell Biol, 210(3):435-450.

[20]PereiraMJ, PalmingJ, RizellM, et al., 2013. The immunosuppressive agents rapamycin, cyclosporin A and tacrolimus increase lipolysis, inhibit lipid storage and alter expression of genes involved in lipid metabolism in human adipose tissue. Mol Cell Endocrinol, 365(2):260-269.

[21]QiangWD, ShenTZ, NomanM, et al., 2021. Fibroblast growth factor 21 augments autophagy and reduces apoptosis in damaged liver to improve tissue regeneration in zebrafish. Front Cell Dev Biol, 9:756743.

[22]QinH, SongZY, ZhaoCY, et al., 2022. Liquiritigenin inhibits lipid accumulation in 3T3-L1 cells via mTOR-mediated regulation of the autophagy mechanism. Nutrients, 14(6):1287.

[23]RostaingL, Sánchez-FructuosoA, FrancoA, et al., 2012. Conversion to tacrolimus once-daily from ciclosporin in stable kidney transplant recipients: a multicenter study. Transpl Int, 25(4):391-400.

[24]RyanA, HeathS, CookP, 2018. Dyslipidaemia and cardiovascular risk. BMJ, 360:k835.

[25]SettembreC, di MaltaC, PolitoVA, et al., 2011. TFEB links autophagy to lysosomal biogenesis. Science, 332(6036):1429-1433.

[26]SheQY, BaoJF, WangHZ, et al., 2022. Fibroblast growth factor 21: a “rheostat” for metabolic regulation? Metabolism, 130:155166.

[27]SuiY, ChenJP, 2022. Hepatic FGF21: its emerging role in inter-organ crosstalk and cancers. Int J Biol Sci, 18(15):‍5928-5942.

[28]TaoZP, AslamH, ParkeJ, et al., 2022. Mechanisms of autophagic responses to altered nutritional status. J Nutr Biochem, 103:108955.

[29]VerouxM, TallaritaT, CoronaD, et al., 2011. Sirolimus in solid organ transplantation: current therapies and new frontiers. Immunotherapy, 3(12):1487-1497.

[30]VisvikisO, IhuegbuN, LabedS, et al., 2014. Innate host defense requires TFEB-mediated transcription of cytoprotective and antimicrobial genes. Immunity, 40(6):896-909.

[31]WangSY, LiHY, YuanMH, et al., 2022. Role of AMPK in autophagy. Front Physiol, 13:1015500.

[32]WangYH, WangYL, LiF, et al., 2022. Psoralen suppresses lipid deposition by alleviating insulin resistance and promoting autophagy in oleate-induced L02 cells. Cells, 11(7):1067.

[33]WuAM, FengB, YuJ, et al., 2021. Fibroblast growth factor 21 attenuates iron overload-induced liver injury and fibrosis by inhibiting ferroptosis. Redox Biol, 46:102131.

[34]YanLS, ZhangSF, LuoG, et al., 2022. Schisandrin B mitigates hepatic steatosis and promotes fatty acid oxidation by inducing autophagy through AMPK/mTOR signaling pathway. Metabolism, 131:155200.

[35]ZhangCZ, ChenKC, WeiRL, et al., 2020. The circFASN/miR-33a pathway participates in tacrolimus-induced dysregulation of hepatic triglyceride homeostasis. Signal Transduct Target Ther, 5:23.

[36]ZhangT, LiuJX, ShenSN, et al., 2020. SIRT3 promotes lipophagy and chaperon-mediated autophagy to protect hepatocytes against lipotoxicity. Cell Death Differ, 27(1):329-344.